BDBM50115032 1-{3-[4-(4-Fluoro-benzyl)-piperidin-1-yl]-propyl}-3-[3-(1-methyl-1H-tetrazol-5-yl)-phenyl]-urea::CHEMBL43173

SMILES Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1

InChI Key InChIKey=NBCZORXSDNGHOO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50115032   

TargetC-C chemokine receptor type 3(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50115032(1-{3-[4-(4-Fluoro-benzyl)-piperidin-1-yl]-propyl}-...)
Affinity DataIC50:  5nMAssay Description:Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]-eotaxin.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetC-C chemokine receptor type 3(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50115032(1-{3-[4-(4-Fluoro-benzyl)-piperidin-1-yl]-propyl}-...)
Affinity DataIC50:  5nMAssay Description:In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed